NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS

The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor sub...

Full description

Saved in:
Bibliographic Details
Main Authors SZABÓ, György, KAPUS, Gábor László, POTOR, Attila, VÁGÓ, István, TÚRÓS, György István, ÉLIÁS, Olivér
Format Patent
LanguageEnglish
French
Published 30.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA α5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA α5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments. La présente invention concerne des composés de formule (I) et/ou des sels et/ou des métabolites biologiquement actifs et/ou des promédicaments et/ou des solvates et/ou des hydrates et/ou des polymorphes de ceux-ci ayant une affinité et une sélectivité pour la sous-unité alpha 5 du récepteur de l'acide gamma-aminobutyrique A et qui agissent en tant que modulateurs allostériques positifs de GABAA α5, ce qui est utile dans le traitement ou la prévention de maladies associées au récepteur GABAA α5, un procédé pour leur préparation et des intermédiaires pour le procédé de préparation de ceux-ci, des compositions pharmaceutiques les comprenant seuls ou en combinaison avec un ou plusieurs autres principes actifs et leur utilisation en tant que médicaments.
AbstractList The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA α5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA α5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments. La présente invention concerne des composés de formule (I) et/ou des sels et/ou des métabolites biologiquement actifs et/ou des promédicaments et/ou des solvates et/ou des hydrates et/ou des polymorphes de ceux-ci ayant une affinité et une sélectivité pour la sous-unité alpha 5 du récepteur de l'acide gamma-aminobutyrique A et qui agissent en tant que modulateurs allostériques positifs de GABAA α5, ce qui est utile dans le traitement ou la prévention de maladies associées au récepteur GABAA α5, un procédé pour leur préparation et des intermédiaires pour le procédé de préparation de ceux-ci, des compositions pharmaceutiques les comprenant seuls ou en combinaison avec un ou plusieurs autres principes actifs et leur utilisation en tant que médicaments.
Author TÚRÓS, György István
ÉLIÁS, Olivér
VÁGÓ, István
KAPUS, Gábor László
SZABÓ, György
POTOR, Attila
Author_xml – fullname: SZABÓ, György
– fullname: KAPUS, Gábor László
– fullname: POTOR, Attila
– fullname: VÁGÓ, István
– fullname: TÚRÓS, György István
– fullname: ÉLIÁS, Olivér
BookMark eNrjYmDJy89L5WQI83MM8AjxiAzydPH0c1Vw9HNRCABx_KONdUx0k2PBHMcokJyLa5BnmGOIZ5hrsIJjsIK7o5Ojo8K5jaYKQa7OrgEh_kEKvv4uoT6OQFYwDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2JD_c3MjAyNLQ0tDC2cDQ0Jk4VACfWNJQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DÉRIVÉS DE NAPHTYRIDINE ET DE PYRIDO[3,4-C]PYRIDAZINE SERVANT DE MODULATEURS DU RÉCEPTEUR GABAA α5
ExternalDocumentID WO2021191838A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2021191838A13
IEDL.DBID EVB
IngestDate Fri Jul 26 04:35:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2021191838A13
Notes Application Number: WO2021IB52486
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210930&DB=EPODOC&CC=WO&NR=2021191838A1
ParticipantIDs epo_espacenet_WO2021191838A1
PublicationCentury 2000
PublicationDate 20210930
PublicationDateYYYYMMDD 2021-09-30
PublicationDate_xml – month: 09
  year: 2021
  text: 20210930
  day: 30
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies RICHTER GEDEON NYRT
RelatedCompanies_xml – name: RICHTER GEDEON NYRT
Score 3.3552675
Snippet The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210930&DB=EPODOC&locale=&CC=WO&NR=2021191838A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fS8MwEA9jivqmU_HPlIDSJ4vb-v9hSNZ0duLa0nV1KjKWbAVBuuEqfi6_iJ_JS9x0T3u7y0FIDi53v-TugtBlnWWWM7YaKvgirupc09TROOMqMyA-rTuZCLJFtkVg-n39bmAMSuhtWQsj-4R-yuaIYFEc7L2Q5_Xs_xKLytzK-TV7haHpTTtpUmWBjhuiOVJNoa2mF4U0dBXXBdymBLGUATSxNZsAVtqAQNoS9uClLVGXMlt1Ku1dtBnBfHmxh0qTvIK23eXfaxW01V08eQO5sL75PkoDEvmJ_xh3aCfwMAkojgQTPmtXuspfJEOehIwCPktJ0km9HiY9fEtahODvLwPHnutFSRjjbkj79wSo3gG6aHuJ66uwwOGfPoYP4eputENUzqf55AhhQ_wd7NgN3XBMnVk1e6SNs4zVOTNM27T4Maqum-lkvfgU7Qj2N1miisrF-8fkDDxywc6lIn8Al5mH7Q
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEL8QNOKbosY_qE00e3IR2P8HYso63BS2ZYyJGkPYYImJASIzfi6_iJ_J6wTlibe2lzTtJb_e_drrHcBlLU41Y6TVRbRFiSgnkiQOR2kixgr6pzUj5U42j7ZwVbsn3_WVfgHeln9h8jyhn3lyRERUgnjP8vN69n-JxfLYyvl1_IpD05tW2GDCgh3XeXKkqsCaDcv3mGcKpom8TXCDXIbURJd0ilxpA51sjePBipr8X8ps1ai0dmDTx_km2S4UxpMylMxl7bUybHUWT97YXKBvvgeRS307tB8DhzmuRajLiM873rN0JYvJS96hT1zGkJ9FNHQiq0tol9zSJqXk-0shgWVafugFpOOxXptiq7sPFy0rNG0RFzj408fgwVvdjXQAxcl0Mj4EovDawYZelxVDlWOtqg-lUZrGtSRWVF3VkiOorJvpeL34HEp22GkP2o57fwLbXPQbOFGBYvb-MT5F65zFZ7lSfwAkMYrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NAPHTHYRIDINE+AND+PYRIDO%5B3%2C4-c%5DPYRIDAZINE+DERIVATIVES+AS+GABAA+%CE%B15+RECEPTOR+MODULATORS&rft.inventor=SZAB%C3%93%2C+Gy%C3%B6rgy&rft.inventor=KAPUS%2C+G%C3%A1bor+L%C3%A1szl%C3%B3&rft.inventor=POTOR%2C+Attila&rft.inventor=V%C3%81G%C3%93%2C+Istv%C3%A1n&rft.inventor=T%C3%9AR%C3%93S%2C+Gy%C3%B6rgy+Istv%C3%A1n&rft.inventor=%C3%89LI%C3%81S%2C+Oliv%C3%A9r&rft.date=2021-09-30&rft.externalDBID=A1&rft.externalDocID=WO2021191838A1